Ignite Creation Date:
2024-05-06 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT05999838
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-21
First Post:
2023-07-11
Brief Title:
HR Chest CT Visual Scoring Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
High-resolution Chest CT Visual Scoring Spirometry and Health Related Quality of Life in Evaluating Severity of Interstitial Lung Disease Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To establish a simplified approach for assessment of severity of interstitial lung disease by evaluating the relationship between HRCT findings the clinical severity scorespirometry and quality of life
Detailed Description:
The interstitial lung diseases are a group of parenchymal pulmonary disorders that affect the interstitium causing progressive fibrosis of lung tissue These disorders characterized by dyspnea aggravated by exertion This group of diseases is associated with substantial morbidity and mortality Thus a multi-disciplinary approach including clinical pathological and radiological correlation is required to reach accurate assessment The high-resolution computed tomography HRCT images of the chest are considered the main platform for the diagnostic approach High-resolution CT HRCT scans offer the possibility of measuring disease severity more accurately and sensitively by focusing on fibrotic changes HRCT images illustrate the presence and extent of parenchymal abnormalities including reticular opacities ground-glass opacities traction bronchiectasis and honeycombing Most patients with suspected ILDs are likely to undergo complete Pulmonary Function Testing Usually there is restrictive pulmonary function with decreased TLC Total Lung Capacity FVC Forced Vital Capacity FEV1 Forced Expiratory Volume in One Second and a normal or increased FEV1FVC ratio
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None